67 Pages Posted: 11 Jun 2008 Last revised: 23 Feb 2014
Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of research to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments of the pharmaceutical global value chain.
Keywords: pharmaceuticals, innovaiton, R&D, value chain, China, India
Suggested Citation: Suggested Citation
Wadhwa, Vivek and Rissing, Ben A. and Gereffi, G. and Trumpbour, John and Engardio, Pete, The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market. Available at SSRN: https://ssrn.com/abstract=1143472 or http://dx.doi.org/10.2139/ssrn.1143472